FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease

Drugs mentioned

• EFFIENT (prasugrel hydrochloride)

Snippet

SUPPL AP for EFFIENT (PRASUGREL HYDROCHLORIDE)